STIMULAN VG

COMBINATION_PRODUCT3 trials

Sponsors

Biocomposites Ltd

Conditions

Diabetic Foot OsteomyelitisOsteomyelitisPressure Ulcer, Stage IVStage IV Pressure Ulcer

Phase 2

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

Active, not recruitingNCT05539963

Biocomposites LtdDiabetic Foot Osteomyelitis

Start: 2023-01-23End: 2025-12-30Updated: 2025-06-24

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

RecruitingNCT06283979

Biocomposites LtdOsteomyelitis, Pressure Ulcer, Stage IV

Start: 2025-06-15End: 2026-12-01Target: 60Updated: 2026-02-23

Unknown Phase

Expanded Access Program (EAP) STIMULAN VG

Biocomposites LtdDiabetic Foot Osteomyelitis, Stage IV Pressure Ulcer

Updated: 2025-02-05